Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone

By Wiesinger Herbert  

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 673-684

Adis International

Access to resources Recommend Favorite

The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring

By Wagner Marie-Soleil   Arias Raquel D   Nucatola Deborah L  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1769-1777

Informa Healthcare

Access to resources Recommend Favorite

Safety of a New Oral Contraceptive Containing Drospirenone

By Lothar A.J. Heinemann  

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 1001-1018

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20µg and Drospirenone 3mg

By Cibula D.  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 143-150

Adis International

Access to resources Recommend Favorite

Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone: Results of Three Multicentre Trials

By Bitzer Johannes  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 73-78

Adis International

Access to resources Recommend Favorite